Skip to main content
Fig. 4 | Arthritis Research & Therapy

Fig. 4

From: Connective tissue remodelling is differently modulated by tocilizumab versus methotrexate monotherapy in patients with early rheumatoid arthritis: the AMBITION study

Fig. 4

Treatment-dependent difference in inflammatory biomarker profiles of patients assigned as ACR50 responders (black bars) and ACR50 non-responders (grey bars) from baseline to week 8 and predictive profiles at week 24. Figures represent serum levels of CRPM (a) (TCZ n = 143; MTX n = 145) and CRP (b) (TCZ n = 164; MTX n = 161) in response to TCZ and MTX at week 8 and predictive profiles at week 24. Data are shown as mean with SEMs

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us